• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

营养不良型糖尿病患者的安替比林动力学

Antipyrine kinetics in undernourished diabetics.

作者信息

Shobha J C, Raghuram T C, Kumar A D, Krishnaswamy K

机构信息

Department of Pharmacology Gandhi Medical College, Hyderabad, India.

出版信息

Eur J Clin Pharmacol. 1991;41(4):359-61. doi: 10.1007/BF00314968.

DOI:10.1007/BF00314968
PMID:1804653
Abstract

In developing countries diabetics frequently suffer from varying grades of malnutrition. The combined effect of malnutrition and non-insulin dependent diabetes (NIDDM) on the drug metabolising enzyme system has been evaluated using antipyrine as a protodrug. All the patients were under treatment and their plasma glucose values were within normal limits. The AUC of antipyrine was similar in all the groups. Although none of the kinetic parameters was altered in normal diabetics, the clearance of antipyrine was decreased and its half life was prolonged, with an increase in volume of distribution, in undernourished diabetics compared to undernourished controls. The results indicate that diabetes per se may not influence antipyrine kinetics when the blood glucose is well under control, but in the presence of undernutrition, it significantly alters the disposition of the drug.

摘要

在发展中国家,糖尿病患者常常伴有不同程度的营养不良。以安替比林作为原型药物,评估了营养不良与非胰岛素依赖型糖尿病(NIDDM)对药物代谢酶系统的联合作用。所有患者均在接受治疗,且其血浆葡萄糖值在正常范围内。安替比林的曲线下面积在所有组中相似。虽然正常糖尿病患者的动力学参数均未改变,但与营养不良的对照组相比,营养不良的糖尿病患者安替比林的清除率降低,半衰期延长,分布容积增加。结果表明,当血糖得到良好控制时,糖尿病本身可能不会影响安替比林的动力学,但在存在营养不良的情况下,它会显著改变药物的处置。

相似文献

1
Antipyrine kinetics in undernourished diabetics.营养不良型糖尿病患者的安替比林动力学
Eur J Clin Pharmacol. 1991;41(4):359-61. doi: 10.1007/BF00314968.
2
Microsomal enzymes in malnutrition as determined by plasma half life of antipyrine.通过安替比林血浆半衰期测定营养不良中的微粒体酶。
Br Med J. 1977 Feb 26;1(6060):538-40. doi: 10.1136/bmj.1.6060.538.
3
Differential effect of type I and type II diabetes mellitus on antipyrine elimination.I型和II型糖尿病对安替比林消除的差异效应。
Methods Find Exp Clin Pharmacol. 1989 Dec;11(12):755-8.
4
Differential effect of type I and type II diabetes on antipyrine disposition in man.I型和II型糖尿病对人体安替比林代谢的不同影响。
Eur J Clin Pharmacol. 1988;34(4):369-75. doi: 10.1007/BF00542438.
5
Diabetes and elimination of antipyrine in man: an analysis of 298 patients classified by type of diabetes, age, sex, duration of disease and liver involvement.糖尿病与人体中安替比林的消除:对298例按糖尿病类型、年龄、性别、病程和肝脏受累情况分类的患者的分析。
Pharmacol Toxicol. 2002 Mar;90(3):155-60. doi: 10.1034/j.1600-0773.2002.900308.x.
6
Disposition of antipyrine and phenytoin correlated with age and liver volume in man.安替比林和苯妥英在人体内的处置与年龄及肝脏体积相关。
Clin Pharmacokinet. 1981 Sep-Oct;6(5):389-96. doi: 10.2165/00003088-198106050-00005.
7
Effects of age, sex and breed on antipyrine disposition in calves.
Res Vet Sci. 1988 Mar;44(2):135-9.
8
Drug metabolism in diabetic subjects with fatty livers.患有脂肪肝的糖尿病患者的药物代谢
Br J Clin Pharmacol. 1984 Dec;18(6):895-9. doi: 10.1111/j.1365-2125.1984.tb02561.x.
9
Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.慢性活动性肝炎和酒精性肝硬化患者的肝血流量、安替比林清除率及安替比林代谢产物形成清除率
Br J Clin Pharmacol. 1994 Apr;37(4):375-81. doi: 10.1111/j.1365-2125.1994.tb04292.x.
10
Hepatic glucose-6-phosphatase activity in non-insulin dependent diabetics. Effect of enzyme-inducing drugs.非胰岛素依赖型糖尿病患者的肝脏葡萄糖-6-磷酸酶活性。酶诱导药物的作用。
Acta Med Scand. 1984;215(4):323-31. doi: 10.1111/j.0954-6820.1984.tb05014.x.

引用本文的文献

1
Prediction of drug disposition in diabetic patients by means of a physiologically based pharmacokinetic model.通过基于生理的药代动力学模型预测糖尿病患者的药物处置情况。
Clin Pharmacokinet. 2015 Feb;54(2):179-93. doi: 10.1007/s40262-014-0192-8.
2
Scaling basic toxicokinetic parameters from rat to man.将大鼠的基本毒代动力学参数外推至人体。
Environ Health Perspect. 1996 Apr;104(4):400-7. doi: 10.1289/ehp.96104400.

本文引用的文献

1
The evaluation of the drug-metabolizing capacity in patients with diabetes mellitus.
Diabetes. 1980 Oct;29(10):788-94. doi: 10.2337/diacare.20.10.788.
2
Further observations on relationships between antipyrine half-life, clearance and volume of distribution: an appraisal of alternative kinetic parameters used to assess the elimination of antipyrine.关于安替比林半衰期、清除率和分布容积之间关系的进一步观察:对用于评估安替比林消除的替代动力学参数的评估。
Clin Pharmacokinet. 1980 May-Jun;5(3):263-73. doi: 10.2165/00003088-198005030-00005.
3
Effect of diabetes on rat liver cytochrome P-450. Evidence for a unique diabetes-dependent rat liver cytochrome P-450.糖尿病对大鼠肝脏细胞色素P-450的影响。一种独特的依赖糖尿病的大鼠肝脏细胞色素P-450的证据。
Biochem Pharmacol. 1982 Oct 15;31(20):3329-34. doi: 10.1016/0006-2952(82)90569-x.
4
Antipyrine metabolism in patients with diabetes mellitus.糖尿病患者的安替比林代谢
Clin Exp Pharmacol Physiol. 1983 Jan-Feb;10(1):7-13. doi: 10.1111/j.1440-1681.1983.tb00165.x.
5
Drug metabolism in diabetic subjects with fatty livers.患有脂肪肝的糖尿病患者的药物代谢
Br J Clin Pharmacol. 1984 Dec;18(6):895-9. doi: 10.1111/j.1365-2125.1984.tb02561.x.
6
A survey of diabetes mellitus in a rural population of India.
Diabetes. 1972 Dec;21(12):1192-6. doi: 10.2337/diab.21.12.1192.
7
Role of nutrition in the drug-metabolizing enzyme system.
Pharmacol Rev. 1974 Sep;26(3):171-97.
8
Impairment of drug clearance in patients with diabetes mellitus & liver cirrhosis.糖尿病和肝硬化患者的药物清除受损。
Indian J Med Res. 1987 Mar;85:321-5.
9
Differential effect of type I and type II diabetes on antipyrine disposition in man.I型和II型糖尿病对人体安替比林代谢的不同影响。
Eur J Clin Pharmacol. 1988;34(4):369-75. doi: 10.1007/BF00542438.
10
Influences of diet and nutrition on clinical pharmacokinetics.饮食和营养对临床药代动力学的影响。
Clin Pharmacokinet. 1988 Jun;14(6):325-46. doi: 10.2165/00003088-198814060-00002.